Linagliptin (Compound)

Synonyms:Linagliptin, 668270-12-0, Tradjenta, BI 1356, BI-1356, Ondero, Linagliptin (BI-1356), Trajenta, Trazenta, BI-1356-BS, BS 1356 BS, ione, 3X29ZEJ4R2, CHEMBL237500, (R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione, BI-1356BS, CHEBI:68610, BI 1356 BS, BS-1356-BS, (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, (R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione, 8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione, 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione, 8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3- methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione, 8-[(3r)-3-Aminopiperidin-1-Yl]-7-But-2-Yn-1-Yl-3-Methyl-1-[(4-Methylquinazolin-2-Yl)methyl]-3,7-Dihydro-1h-Purine-2,6-Dione, C25H28N8O2, UNII-3X29ZEJ4R2, Linaglitpin, Linagliptin [USAN:INN:JAN], HSDB 8204, Tradjenta (TN), 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione, LINAGLIPTIN [MI], LINAGLIPTIN [INN], LINAGLIPTIN [JAN], LINAGLIPTIN [USAN], LINAGLIPTIN [VANDF], LINAGLIPTIN [MART.], LINAGLIPTIN [WHO-DD], MLS006010217, SCHEMBL160188, Linagliptin (JAN/USAN/INN), GTPL6318, AMY8953, EX-A076, LINAGLIPTIN [ORANGE BOOK], BCPP000185, DTXSID201021653, BCP02462, BDBM50228403, GLYXAMBI COMPONENT LINAGLIPTIN, MFCD14635356, s3031, AKOS015951179, AKOS015995251, AC-8761, BCP9000854, CCG-269463, CS-0637, DB08882, LINAGLIPTIN COMPONENT OF GLYXAMBI, TRIJARDY XR COMPONENT LINAGLIPTIN, NCGC00346655-01, NCGC00346655-02, 1H-Purine-2,6-dione, 8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-, AS-35080, BL164627, HY-10284, JENTADUETO COMPONENT OF LINAGLIPTIN, LINAGLIPTIN COMPONENT OF JENTADUETO, SMR004701306, LINAGLIPTIN COMPONENT OF TRIJARDY XR, SW219813-1, D09566, AB01563307_01, AB01563307_03, EN300-6481354, Q909745, J-519354, Z2235801970, (R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione, 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-aminopiperidin-1-yl)xanthine, 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)aminopiperidin-1-yl)xanthine, 1-[(4-methyl-quinazolin-2yl) methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R) amino-piperidin-1-yl]-xanthine, 1-[(4-Methylquinazolin-2-yl)-methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine, 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine, 1233245-11-8, 1H-PURINE-2,6-DIONE, 8-((3R)-3-AMINO-1-PIPERIDINYL)-7-(2-BUTYNYL)-3,7-DIHYDRO-3-METHYL-1-((4-METHYL-2- QUINAZOLINYL)METHYL)-, 8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione, 8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-d ione, Linagliptin; (R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione

Id:10096344

Description:nan